Advanced Cell Technology Inc. (OTC: ACTC), a biotechnology company engaged in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine, has seen a sharp decline in early trading today.
Continue reading Micro-Cap on Watch; Advanced Cell Technology Inc. (ACTC)